S El Kadi1, T R Porter2, A C van Rossum3, O Kamp3. 1. Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands. s.elkadi@amsterdamumc.nl. 2. Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, NE, USA. 3. Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Treatment of ST-elevation myocardial infarction (STEMI) has improved over the years. Current challenges in the management of STEMI are achievement of early reperfusion and the prevention of microvascular injury. Sonothrombolysis has emerged as a potential treatment for acute myocardial infarction, both for epicardial recanalisation as well as improving microvascular perfusion. This study aims to determine safety and feasibility of sonothrombolysis application in STEMI patients in the ambulance. METHODS: Ten patients with STEMI will be included and treated with sonothrombolysis in the ambulance during transfer to the PCI centre. Safety will be assessed by the occurrence of ventricular arrhythmias and shock during sonothrombolysis intervention. Feasibility will be assessed by the extent of protocol completion and myocardial visibility. Efficacy will be determined by angiographic patency rate, ST-elevation resolution, infarct size and left ventricular volumes, and function measured with cardiovascular magnetic resonance imaging, and contrast and strain echocardiography. A comparison will be made with matched controls using an existing STEMI database. DISCUSSION: Sonothrombolysis is a novel technique for the treatment of cardiovascular thromboembolic disease. The first clinical trials on its use for STEMI have demonstrated promising results. This study will be the first to examine the feasibility of in-ambulance sonothrombolysis for STEMI. TRIAL REGISTRATION: EU Clinical Trials Register (identifier: 2019-001883-31), registered 2020-02-25.
BACKGROUND: Treatment of ST-elevation myocardial infarction (STEMI) has improved over the years. Current challenges in the management of STEMI are achievement of early reperfusion and the prevention of microvascular injury. Sonothrombolysis has emerged as a potential treatment for acute myocardial infarction, both for epicardial recanalisation as well as improving microvascular perfusion. This study aims to determine safety and feasibility of sonothrombolysis application in STEMI patients in the ambulance. METHODS: Ten patients with STEMI will be included and treated with sonothrombolysis in the ambulance during transfer to the PCI centre. Safety will be assessed by the occurrence of ventricular arrhythmias and shock during sonothrombolysis intervention. Feasibility will be assessed by the extent of protocol completion and myocardial visibility. Efficacy will be determined by angiographic patency rate, ST-elevation resolution, infarct size and left ventricular volumes, and function measured with cardiovascular magnetic resonance imaging, and contrast and strain echocardiography. A comparison will be made with matched controls using an existing STEMI database. DISCUSSION: Sonothrombolysis is a novel technique for the treatment of cardiovascular thromboembolic disease. The first clinical trials on its use for STEMI have demonstrated promising results. This study will be the first to examine the feasibility of in-ambulance sonothrombolysis for STEMI. TRIAL REGISTRATION: EU Clinical Trials Register (identifier: 2019-001883-31), registered 2020-02-25.
Authors: Peter J McCartney; Hany Eteiba; Annette M Maznyczka; Margaret McEntegart; John P Greenwood; Douglas F Muir; Saqib Chowdhary; Anthony H Gershlick; Clare Appleby; James M Cotton; Andrew Wragg; Nick Curzen; Keith G Oldroyd; Mitchell Lindsay; J Paul Rocchiccioli; Aadil Shaukat; Richard Good; Stuart Watkins; Keith Robertson; Christopher Malkin; Lynn Martin; Lynsey Gillespie; Thomas J Ford; Mark C Petrie; Peter W Macfarlane; R Campbell Tait; Paul Welsh; Naveed Sattar; Robin A Weir; Keith A Fox; Ian Ford; Alex McConnachie; Colin Berry Journal: JAMA Date: 2019-01-01 Impact factor: 56.272
Authors: Vincent Roolvink; Borja Ibáñez; Jan Paul Ottervanger; Gonzalo Pizarro; Niels van Royen; Alonso Mateos; Jan-Henk E Dambrink; Noemi Escalera; Erik Lipsic; Agustín Albarran; Antonio Fernández-Ortiz; Francisco Fernández-Avilés; Javier Goicolea; Javier Botas; Wouter Remkes; Victoria Hernandez-Jaras; Elvin Kedhi; José L Zamorano; Felipe Navarro; Fernando Alfonso; Alberto García-Lledó; Joaquin Alonso; Maarten van Leeuwen; Robin Nijveldt; Sonja Postma; Evelien Kolkman; Marcel Gosselink; Bart de Smet; Saman Rasoul; Jan J Piek; Valentin Fuster; Arnoud W J van 't Hof Journal: J Am Coll Cardiol Date: 2016-04-03 Impact factor: 24.094
Authors: Azam Torabi; John G F Cleland; Nasrin K Khan; Puan H Loh; Andrew L Clark; Farqad Alamgir; John L Caplin; Alan S Rigby; Kevin Goode Journal: Eur Heart J Date: 2008-03-19 Impact factor: 29.983
Authors: Matthijs van Kranenburg; Michael Magro; Holger Thiele; Suzanne de Waha; Ingo Eitel; Alexandre Cochet; Yves Cottin; Dan Atar; Peter Buser; Edwin Wu; Daniel Lee; Vicente Bodi; Gert Klug; Bernhard Metzler; Ronak Delewi; Peter Bernhardt; Wolfgang Rottbauer; Eric Boersma; Felix Zijlstra; Robert-Jan van Geuns Journal: JACC Cardiovasc Imaging Date: 2014-09
Authors: David Carrick; Caroline Haig; Sam Rauhalammi; Nadeem Ahmed; Ify Mordi; Margaret McEntegart; Mark C Petrie; Hany Eteiba; Stuart Hood; Stuart Watkins; Mitchell Lindsay; Ahmed Mahrous; Ian Ford; Niko Tzemos; Naveed Sattar; Paul Welsh; Aleksandra Radjenovic; Keith G Oldroyd; Colin Berry Journal: Eur Heart J Date: 2015-08-10 Impact factor: 29.983
Authors: Sheraz A Nazir; Gerry P McCann; John P Greenwood; Vijay Kunadian; Jamal N Khan; Islam Z Mahmoud; Daniel J Blackman; Martin Been; Keith R Abrams; Lorraine Shipley; Robert Wilcox; A A Jennifer Adgey; Anthony H Gershlick Journal: Eur Heart J Date: 2016-05-04 Impact factor: 29.983
Authors: Derek J Hausenloy; Rajesh K Kharbanda; Ulla Kristine Møller; Manish Ramlall; Jens Aarøe; Robert Butler; Heerajnarain Bulluck; Tim Clayton; Ali Dana; Matthew Dodd; Thomas Engstrom; Richard Evans; Jens Flensted Lassen; Erika Frischknecht Christensen; José Manuel Garcia-Ruiz; Diana A Gorog; Jakob Hjort; Richard F Houghton; Borja Ibanez; Rosemary Knight; Freddy K Lippert; Jacob T Lønborg; Michael Maeng; Dejan Milasinovic; Ranjit More; Jennifer M Nicholas; Lisette Okkels Jensen; Alexander Perkins; Nebojsa Radovanovic; Roby D Rakhit; Jan Ravkilde; Alisdair D Ryding; Michael R Schmidt; Ingunn Skogstad Riddervold; Henrik Toft Sørensen; Goran Stankovic; Madhusudhan Varma; Ian Webb; Christian Juhl Terkelsen; John P Greenwood; Derek M Yellon; Hans Erik Bøtker Journal: Lancet Date: 2019-09-06 Impact factor: 79.321